iRhythm Technologies (NASDAQ:IRTC) held its 2026 annual meeting of stockholders virtually on Wednesday, May 27, with shareholders approving all five proposals presented at the meeting, according to preliminary voting results.
Quentin Blackford, iRhythm’s president and chief executive officer, served as chairman of the meeting. He said the company was hosting the annual meeting virtually to facilitate “increased stockholder access and lower costs.” Members of the company’s board of directors and executive leadership team were on the call, along with Emad Fareed of KPMG LLP, the company’s independent accountants. Susan Kraus, corporate secretary, served as secretary of the meeting, and Susan Miller served as inspector of election.
Five Proposals Presented to Stockholders
The company brought five items of formal business before stockholders. The first proposal was the election of nine directors to serve one-year terms expiring at the 2027 annual meeting of stockholders.
The nominees named by the board were:
- Quentin Blackford
- Abhijit Talwalkar
- Noel Bairey Merz, MD
- Bruce Bodaken
- Karen Ling
- Karen McGinnis
- Kevin O’Boyle
- Jason Patten
- Brian Yoor
The second proposal sought approval of the iRhythm 2026 Equity Incentive Plan, as described in the company’s proxy statement. The third proposal asked stockholders to approve an amended and restated certificate of incorporation to remove the company’s pass-through voting provision.
The fourth proposal was the ratification of the audit committee’s selection of KPMG LLP as iRhythm’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. The fifth proposal was a non-binding advisory vote to approve the compensation of the company’s named executive officers.
Preliminary Results Show Approval of All Items
Voting was conducted electronically during the meeting. Blackford opened the polls at 9:05 a.m. Pacific Time and closed them one minute later, after giving stockholders the opportunity to vote or change previously submitted votes.
Miller, the inspector of election, reported that preliminary results showed each of the five proposals had received the required number of votes to pass.
“Based on the preliminary results, each of the proposals numbered one through five has received the requisite number of votes needed to pass,” Miller said.
Blackford then adjourned the meeting and said any questions submitted by stockholders would be answered directly in follow-up after the meeting.
About iRhythm Technologies (NASDAQ:IRTC)
iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.
The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.
